SOPHiA GENETICS SA

SOPHiA GENETICS SA

World Rank (Jan-05-2024)
15,258
Market Cap (Jan-05-2024)
0.326 Billion USD
World Rank (Jul-30-2023)
16,911
Market Cap (Jul-30-2023)
0.248 Billion USD
World Rank (Jan-07-2022)
10,443
Market Cap (Jan-07-2022)
0.827 Billion USD
Headquarters Country
Switzerland
Nasdaq / NYSE Code
SOPH
Market Cap (Mar-08-2026)
0.31
World Region
Europe
World Subregion
Western Europe
Business Sector
Healthcare Technology and Information
Company Website
SOPHIA GENETICS SA
Company Profile
Sophia Genetics SA is a healthcare technology company to diseases such as cancer and inherited disorders where combining genomic and phenotypic information is vital to support discoveries, treatment decisions and drug development efforts. The company annual revenue is 28.4 million USD and total assets are 132.1 million USD as on 2020. The headquarters is in Switzerland.
IPO Year
2021
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share